|
[PMID]: | 28460061 |
[Au] Autor: | Papaleontiou M; Hughes DT; Guo C; Banerjee M; Haymart MR |
[Ad] Endereço: | Division of Metabolism, Endocrinology, and Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan 48106. |
[Ti] Título: | Population-Based Assessment of Complications Following Surgery for Thyroid Cancer. |
[So] Source: | J Clin Endocrinol Metab;102(7):2543-2551, 2017 Jul 01. | [Is] ISSN: | 1945-7197 |
[Cp] País de publicação: | United States |
[La] Idioma: | eng |
[Ab] Resumo: | Context: As thyroid cancer incidence rises, more patients undergo thyroid surgery. Although postoperative complication rates have been reported in single institution studies, population-based data are limited. Objective: To determine thyroid cancer surgery complication rates and identify at-risk populations. Design/Setting/Patients: Using the Surveillance, Epidemiology, and End Results-Medicare database, we evaluated general complications within 30 days and thyroid surgery-specific complications within 1 year in 27,912 patients who underwent surgery for differentiated or medullary thyroid cancer between 1998 and 2011. Multivariable analyses of patient characteristics associated with postoperative complications were performed. Main Outcome Measures: General and thyroid surgery-specific complications. Results: Overall, 1820 (6.5%) patients developed general postoperative complications and 3427 (12.3%) developed thyroid surgery-specific complications. In multivariable analyses, general and thyroid surgery-specific complications were significantly higher in patients >65 years [odds ratio (OR), 2.61; 95% confidence interval (CI), 2.31 to 2.95; OR, 3.12; 95% CI, 2.85 to 3.42], those with a Charlson/Deyo comorbidity score of 1 (OR, 2.40; 95% CI, 1.66 to 3.49; OR, 1.88; 95% CI, 1.53 to 2.31) and ≥2 (OR, 7.05; 95% CI, 5.33 to 9.56; OR, 3.62; 95% CI, 3.11 to 4.25), and those with regional (OR, 1.18; 95% CI, 1.03 to 1.35; OR, 1.31; 95% CI, 1.19 to 1.45) or distant disease (OR, 2.83; 95% CI, 2.30 to 3.47; OR, 1.85; 95% CI, 1.54 to 2.21), respectively. Conclusions: The rates of thyroid cancer surgery complications are higher than predicted, and patients with older age, more comorbidities, and advanced disease are at greatest risk. Efforts to reduce complications are needed. |
[Mh] Termos MeSH primário: |
Complicações Pós-Operatórias/epidemiologia Neoplasias da Glândula Tireoide/patologia Neoplasias da Glândula Tireoide/cirurgia Tireoidectomia/efeitos adversos
|
[Mh] Termos MeSH secundário: |
Adulto Idoso Intervalo Livre de Doença Feminino Seres Humanos Incidência Modelos Logísticos Masculino Medicare/estatística & dados numéricos Meia-Idade Análise Multivariada Invasividade Neoplásica/patologia Estadiamento de Neoplasias Complicações Pós-Operatórias/fisiopatologia Estudos Retrospectivos Medição de Risco Programa de SEER Análise de Sobrevida Neoplasias da Glândula Tireoide/mortalidade Tireoidectomia/métodos Estados Unidos
|
[Pt] Tipo de publicação: | EVALUATION STUDIES; JOURNAL ARTICLE |
[Em] Mês de entrada: | 1710 |
[Cu] Atualização por classe: | 180308 |
[Lr] Data última revisão:
| 180308 |
[Sb] Subgrupo de revista: | AIM; IM |
[Da] Data de entrada para processamento: | 170502 |
[St] Status: | MEDLINE |
[do] DOI: | 10.1210/jc.2017-00255 |
|
|
|